Achillion names new head of business development
Mr Truitt, who joins Achillion from ViroPharma, which recently acquired Lev Pharmaceuticals, will be responsible for identifying, evaluating and executing corporate partnerships, strategic initiatives and new product opportunities.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.